Catheter Precision (VTAK) Amortization of Goodwill (2023)

Catheter Precision's (VTAK) quarterly Amortization of Goodwill came in at -$34000.0 in Q4 2023, down 100.7% on a QoQ basis from $4.8 million in Q2 2023.

Catheter Precision (VTAK) Amortization of Goodwill (2023) Analysis & Trends

Catheter Precision (VTAK) has 1 years of Amortization of Goodwill data on file, last reported at -$34000.0 in Q4 2023.

  • On a quarterly basis, Amortization of Goodwill changed N/A year-over-year to -$34000.0 in Q4 2023; TTM through Sep 2024 was -$34000.0, a 100.06% decrease from a year earlier, with the FY2023 full-year figure at $60.9 million, changed N/A from the prior year.
  • Amortization of Goodwill for Q4 2023 stood at -$34000.0, down from $4.8 million in the prior quarter.
  • Over the last five years, Amortization of Goodwill for VTAK reached as high as $56.1 million in Q1 2023 and fell as low as -$34000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Catheter Precision 0.80 -811,999.20 390,000.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -34,000.00
Dec 31, 2023 -34,000.00
Jun 30, 2023 4.85 Mn
Jun 30, 2023 4.85 Mn
Mar 31, 2023 56.09 Mn
Mar 31, 2023 56.09 Mn